Press releaseACCESS Newswire
Regenerative Medical Technology Group
RMTG · OTC
$0.04+$0.0024 (+6.38%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseACCESS Newswire
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
- Press releaseACCESS Newswire
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
- Press releaseACCESS Newswire
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
- Press releaseACCESS Newswire
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
- Press releaseACCESS Newswire
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
- Press releaseACCESS Newswire
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
- Press releaseACCESS Newswire
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
- Press releaseACCESS Newswire
Cellgenic Establishes Local Commercial Presence in Brazil
- Press releaseACCESS Newswire
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
- Press releaseACCESS Newswire
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.